Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX.
D000328:Adult; D000368:Aged; D019774:Blood Coagulation Factor Inhibitors / Q000378:metabolism*; D001779:Blood Coagulation Factors / Q000008:administration & dosage* / Q000009:adverse effects; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002648:Child; D003029:Coagulants / Q000008:administration & dosage* / Q000009:adverse effects; D005164:Factor IX / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006467:Hemophilia A / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006488:Hemostasis, Surgical; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D008875:Middle Aged; D016896:Treatment Outcome
D019774:Blood Coagulation Factor Inhibitors; D001779:Blood Coagulation Factors; D003029:Coagulants; D005169:Factor VIII; D005164:Factor IX; C065655:anti-inhibitor coagulant complex